Clinical trials are essential for the development of new medical interventions, but they must also adhere to strict regulatory and ethical guidelines. It’s critical to foster a robust understanding of this regulatory and ethical landscape in Nigeria, says Dayo Adu, Managing Partner at Famsville Solicitors, explaining why the firm is hosting the webinar. “It is imperative that all stakeholders are well-informed about the legal requirements governing these trials. By shedding light on ethical considerations, we aim to contribute to the protection of participants’ rights, thereby fostering a climate of trust and integrity within the clinical trial ecosystem.”
Adu says Nigeria is actively working towards increasing its participation in clinical trials through a multi-faceted approach, including developing guidelines for human research subject protection, identifying ethical principles to guide the conduct of research, and organising training workshops and seminars to build capacity for researchers in research ethics and methodologies.
“The country boasts a large and diverse population, making it an attractive location for clinical research,” he pointed out, adding that the increasing awareness and acceptance of clinical trials within the local medical community also contribute to Nigeria’s growing prominence as a hub for medical research.
Adu says it’s vital that Africa take charge of medical trials and pharmaceutical research happening on the continent. “First and foremost, this will empower African nations to actively contribute to the development of medical treatments that are relevant to the continent’s health challenges. By participating in research, Africa can ensure that the outcomes of clinical trials are representative of its diverse population, leading to more effective and tailored healthcare solutions,” he said. “Furthermore, being at the forefront of medical trials enhances Africa’s position in global health discussions, fostering international collaborations and attracting investments that can strengthen the healthcare infrastructure across the continent.”
Legislation plays a large part in regulating clinical trials, and Adu says improving the country’s legislation in this area will be a catalyst for increased research and potential investment in several ways. “Clear and streamlined regulatory processes instill confidence among researchers and sponsors, reducing bureaucratic hurdles and facilitating the timely initiation of trials. This, in turn, attracts more research initiatives to the country. Enhanced legislation also signifies a commitment to regulatory and ethical standards, ensuring the protection of participants’ rights and data security,” he commented.
Titled “Regulatory and Ethical Considerations in Clinical Trials in Nigeria: Understanding the Legal Requirements and Protecting Participants’ Rights”, the webinar will feature Prof. Cheluchi Onyemelukwe-Onuobia, a leading health lawyer in Nigeria; Dr Afolabi Obe, Chief Medical Officer at SYNLAB Nigeria; Tunde Animashaun, a biotech entrepreneur and co-founder/CEO of Metaphor Laboratory Partners; Dr Laja Odunugu, Medical Director at SmithKlineBeecham; and Dayo Adu, who advises on life sciences and health care, due diligence, regulatory and compliance audits, corporate and internal investigations, and general commercial law.
For more information on the webinar and registration details, click here.
To join Africa Legal's mailing list please click here